NDC71655-0103-01: RAXIBACUMAB INJECTION.
The RAXIBACUMAB INJECTION is a the manufacturer industrial component. Key specifications include part_name_assigned_by_controlling_agency: RAXIBACUMAB INJECTION 1,700 MG/34 ML (50 MG/ML) SINGLE USE VIAL. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-686-9526, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| part_name_assigned_by_controlling_agency | RAXIBACUMAB INJECTION 1,700 MG/34 ML (50 MG/ML) SINGLE USE VIAL |
| NSN | 6505-01-686-9526 |
| SPECIAL FEATURES | INDICATED FOR THE TREATMENT OF ADULT AND PEDIATRIC PATIENTS WITH INHALATIONAL ANTHRAX DUE TO BACILLUS ANTHRACIS IN CONBINATION WITH APPROPRIATE ANTIBACTERIAL DRUGS, AND FOR PROPHYLAXIS OF INHALATIONAL ANTHRAX WHEN ALTERNATIVE THERAPIES ARE NOT AVAILABLE OR ARE NOT APPROPRIATE; FOR INTRAVENOUS INFUSION; MUST BE DILUTED PRIOR TO USE; SINGLE-USE VIAL; DISCARD UNUSED PORTION; TWO VIALS PER DOSE; MUST BE REFRIGERATED AT 2C TO 8C(36F TO 46F); DO NOT FREEZE; PROTECT THE VIAL FROM EXPOSURE TO LIGHT, PRIOR TO USE; BRIEF EXPOSURE TO LIGHT, AS WITH NORMAL USE, IS ACCEPTABLE; STORE VIAL IN ORIGINAL CARTON UNTIL TIME OF USE. 1,700 MG/34 ML (50 MG/ML) SINGLE USE VIAL. |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | RAXIBACUMAB INJECTION 1,700 MG/34 ML (50 MG/ML) SINGLE USE VIAL |